CN Patent

CN117377473A — 生长抑素调节剂用于治疗疾病的用途

Assigned to Crinetics Pharmaceuticals Inc · Expires 2024-01-09 · 2y expired

What this patent protects

本文描述了生长抑素调节剂的制剂、制备此类制剂的方法，以及使用此类制剂治疗将受益于生长抑素活性调节的病状、疾病或病症的方法。

USPTO Abstract

本文描述了生长抑素调节剂的制剂、制备此类制剂的方法，以及使用此类制剂治疗将受益于生长抑素活性调节的病状、疾病或病症的方法。

Drugs covered by this patent

paltusotine-hydrochloride (PALTUSOTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN117377473A
Jurisdiction: CN
Classification: —
Expires: 2024-01-09
Drug substance claim: No
Drug product claim: No
Assignee: Crinetics Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.